August 3, 2021
1 min read

Pfizer, Moderna raise Covid-19 vaccine prices in EU


The supply contracts are being renewed as Europe is anxious to secure supplies for potential booster shots in the face of the spread of the highly infectious Delta variant…reports Asian Lite News.

US drug makers Pfizer and Moderna have increased the prices of their mRNA-based vaccines against Covid-19 for the European market, the media reported.

According to the new contracts, a Pfizer shot will now cost 19.50 euros against 15.50 euros previously, while a Moderna jab has been priced at 21.49 euros a dose, from about 19 euros in the first procurement deal, The Financial Times reported.

The supply contracts are being renewed as Europe is anxious to secure supplies for potential booster shots in the face of the spread of the highly infectious Delta variant.

Further, the terms of the deals, struck this year for a total of up to 2.1 billion shots until 2023, were renegotiated after phase 3 trial data showed the two companies’ mRNA vaccines had higher efficacy rates than shots developed by Oxford/AstraZeneca and Johnson & Johnson, the report said.

The companies had capitalised on their market power and deployed the “usual pharma rhetoric… Vaccines work so they increased the ‘value’,” the report quoted an official close to the negotiations official.

Riding on the success of its Covid vaccine, Pfizer, last week, raised its annual vaccine revenue to $33.5 billion in 2021, up from the previously projected $26 billion.

Prices for higher-income countries were “comparable”, with middle-income countries charged about half and lower-income countries paying cost, Chief executive Albert Bourla was quoted as saying.

Moderna is expected to announce the second quarter financial results this week. According to forecasts compiled by Airfinity, a life sciences consultancy, the sales of Pfizer’s Covid jab will hit 47.1 billion euros with Moderna’s reaching 25.2 billion euros, the FT reported.

On the other hand, sales of Oxford/AstraZeneca’s Covid jab — the largest vaccine supplied to low-income countries — is expected to rise to 12.6 billion euros in 2022, it added.

ALSO READ-‘Pfizer, AZ vax antibodies may drop 50% in 3 months’

READ MORE-Pfizer recommends 3rd Covid shot for Delta variant

Previous Story

Scores of thermal power plants not complying with emission norms

Next Story

EU will not recognise Taliban if they gain power by force

Latest from -Top News

Uganda’s President Museveni to seek reelection

The upcoming general elections will not only determine the presidency but also see voters elect lawmakers to the national assembly Uganda’s President Yoweri Museveni is set to seek reelection for another term

Eritrea seeks to end UN probe into abuses

The mandate in question is held by the Special Rapporteur, a position currently occupied by Sudanese human rights lawyer Mohamed Abdelsalam Babiker In a rare and potentially precedent-setting move, Eritrea is attempting

Alps Turn to ‘Swiss Cheese’

Switzerland’s reliance on glacial runoff for hydroelectric power faces growing risk — as glaciers shrink, short-term water flow may rise, but long-term shortages could threaten energy and water supplies. Switzerland’s glaciers —

Burn Notice for Europe

As summer unfolds, Europe is bracing for what may be the first of many extreme heatwaves. Europe braced for its first major heatwave of the northern hemisphere summer on Saturday, with soaring
Go toTop

Don't Miss

Expert advice on post-vaccine care at home

First of all, you should not worry about the side

Priyanka asks Biden to share Covax for India

“My heart breaks. India is suffering from COVID19 & the